CLIR
ClearSign Technologies Corporation
There isn't enough reported data to score CLIR yet.
VRT
Vertiv Holdings Co
VRT's fundamentals are strong and it looks cheap: trading at 39x earnings, about half its usual 72x. Analysts expect strong earnings growth.
CLIR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
CLIR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CLIR PE Valuation
CLIR has no meaningful PE right now: it lost money over the past year.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
CLIR Forward outlook
There aren't enough analyst estimates for CLIR to show an outlook.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CLIR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.97 | +$0.13 |
| Q1 2026 | -$1.05 | +$0.15 |
| Q4 2025 | -$1.06 | +$0.04 |
| Q3 2025 | -$1.20 | $0.00 |
| Q2 2025 | -$1.10 | +$0.20 |
| Q1 2025 | -$1.20 | +$0.10 |
| Q4 2024 | -$1.10 | +$0.30 |
| Q3 2024 | -$1.20 | +$0.20 |
CLIR is still losing money, but far less than before: $0.97 per share over the past year, against $2.30 at its worst in early 2022.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CLIR on earnings quality, reporting a profit while its opponent remains loss making.
CLIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $560K | +321% |
| Q1 2026 | $191K | -52% |
| Q4 2025 | $3.7M | +522% |
| Q3 2025 | $1M | -45% |
| Q2 2025 | $133K | +196% |
| Q1 2025 | $401K | -64% |
| Q4 2024 | $590K | -54% |
| Q3 2024 | $1.9M | +2087% |
CLIR's revenue is growing: $560,000 last quarter, up 321% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -268% | +1115 points |
| Q1 2026 | -1193% | -630 points |
| Q4 2025 | -23% | +260 points |
| Q3 2025 | -170% | -93 points |
| Q2 2025 | -1382% | +3367 points |
| Q1 2025 | -563% | -449 points |
| Q4 2024 | -282% | -192 points |
| Q3 2024 | -77% | +1684 points |
CLIR's operating margin was −268% last quarter, up 1114 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CLIR on profitability, with a higher operating margin.
CLIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.3M | -$847K |
| Q3 2025 | -$1.8M | -$398K |
| Q1 2025 | -$1.1M | -$114K |
| Q4 2024 | -$436K | +$1M |
| Q4 2023 | -$1.5M | -$717K |
| Q4 2022 | -$733K | +$439K |
| Q3 2022 | -$917K | +$992K |
| Q2 2022 | -$1.8M | +$288K |
VRT has the stronger cash trend. Its trailing FCF is up 337% versus its history, compared with CLIR at up 13%.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
CLIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +304K shares |
| 1 year | +7.4% | +410K shares |
| 3 years | +54% | +2.1M shares |
| 5 years | +89% | +2.8M shares |
CLIR has 6M diluted shares, up 7.4% from a year ago.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has the edge over CLIR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CLIR Net Leverage
CLIR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
CLIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.8 | Neutral |
| Stochastic | 6.6 | Oversold |
CLIR's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CLIR PE vs Industrials Sector
CLIR has no meaningful PE right now: it lost money over the past year.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CLIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.73 | 17% below |
| 20 week MA | $3.48 | 35% below |
| 50 week MA | $4.60 | 51% below |
| 100 week MA | $6.21 | 64% below |
| 200 week MA | $8.03 | 72% below |
CLIR is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over CLIR on trend strength, trading above more of its moving averages.
CLIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.70 | $33.5 | +335% |
| 2021 | $33.5 | $14.5 | -57% |
| 2022 | $14.5 | $6.40 | -56% |
| 2023 | $6.40 | $11.1 | +73% |
| 2024 | $11.1 | $12.2 | +9.9% |
| 2025 | $12.2 | $6.09 | -50% |
| 2026 YTD | $6.09 | $2.26 | -63% |
CLIR's yearly returns have swung widely, from +335% in 2020 to −57% in 2021. It's down 63% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CLIR on returns for 2026, with the stronger performance.